A.R. Timothy

FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma

N. George Mikhaeel, Martin Hutchings, Paul Fields et al. · Annals of Oncology · 2005 · 407 citations · Full text

Medicine, Oncology, Chemotherapy +11

Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma

Martin Hutchings, N. George Mikhaeel, Paul Fields et al. · Annals of Oncology · 2005 · 328 citations · Full text

Medicine, Oncology, Chemotherapy +9

18-FDG-PET as a Prognostic Indicator in the Treatment of Aggressive Non-Hodgkin's Lymphoma-Comparison with CT

N. George Mikhaeel, A.R. Timothy, M. J. OʼDoherty et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2000 · 248 citations

Medicine, Oncology, Radiology +16

Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse

Sharon F. Hain, Michael O’Doherty, A.R. Timothy et al. · British Journal of Cancer · 2000 · 128 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

18-FDG-PET for the assessment of residual masses on CT following treatment of lymphomas

N. George Mikhaeel, A.R. Timothy, Sharon F. Hain et al. · Annals of Oncology · 2000 · 110 citations · Full text

Medicine, Nuclear Medicine, Oncology +12